Graforce presents plasma electrolysers for hydrogen from methane and wastewater on IFAT 2022 fair
25.5.2022 11:00:00 EEST | Business Wire | Press release
Green hydrogen is key to achieving a circular economy. Graforce has developed a plasma electrolysis technology that can produce hydrogen from residual materials – with significantly lower manufacturing costs and higher yields. Graforce will be demonstrating its marketable methane and wastewater electrolysis plants and refueling systems at IFAT, the world’s leading trade fair for water, sewage and waste management. They demonstrate the immense market potential of green hydrogen and the range of applications for CO2-free or even CO2-negative energy and fuel.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220525005029/en/
Graforce plasma electrolysis plants (here a plant in Berlin) produce green hydrogen from methane, wastewater, liquid manure or ammonia. Whereas water electrolysis needs 50kWh/kg H2, the production of 1kg hydrogen from methane takes only 10kWh or 20kWh from wastewater. (Photo: Graforce)
Green hydrogen is projected to have a game changing impact in the mobility, industry, and decentralized energy segments. It plays an important role in meeting global climate goals. The global hydrogen market is forecast to grow by a factor of 6 by 2050. Germany makes up 20 percent of the current European hydrogen consumption and is also forecast to remain the largest hydrogen off-take market in the EU, driven by strong decarbonization commitments across sectors.
The production of hydrogen using plasma electrolysis requires considerably less energy than water electrolysis and leads to significant cost reductions. Whereas water electrolysis needs 50kWh/kg H2, the production of 1kg hydrogen from methane takes only 10kWh or 20kWh from wastewater.
“Whether as fuel, heat source or a raw material, green hydrogen can make a significant contribution to achieving climate targets in many industries,” explains Dr. Jens Hanke. “Our plants produce green hydrogen from methane, wastewater, liquid manure or ammonia. We thus close energy and material cycles and make a significant contribution to a future without fossil fuels and CO2 emissions. And we deliver this quickly and cost-effectively."
For the development and customer-specific scaling of its modular plants, Graforce works with global leaders in the fields of engineering, procurement, and construction. The company is currently in the process of expanding its strategic partnerships with financial as well as strategic investors to quickly scale its technology worldwide.
About
The German company Graforce is a technology leader in sustainable solutions and carbon dioxide removal technologies. The power-to-X plants produce CO2-free or CO2-negative hydrogen and synthetic feedstocks – with the highest efficiency and lower infrastructure costs in the multi-megawatt range. Thus, Graforce decarbonizes fossil energies, industrial sectors and the heat, transport and building sectors. www.graforce.com/EN
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220525005029/en/
Contact information
Graforce GmbH
Dr. Jens Hanke
Phone: +49 30 - 63 2222-110
presse@graforce.de
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Medicines and Revolution Medicines Announce Clinical Development and Regional Commercialization Collaboration10.8.2026 13:00:00 EEST | Press release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, and Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced a multi-part collaboration including: a clinical collaboration to evaluate drug combinations incorporating select clinical-stage oncology assets from BeOne with any of Revolution Medicines’ four clinical RAS(ON) inhibitors, and a separate regional rights agreement granting BeOne exclusive development and commercialization rights to these Revolution Medicines assets in select Asian markets. Clinical collaboration will explore potential targeted combination approaches for patients with RAS-addicted cancers Potential drug combinations for development as part of the clinical collaboration will include certain BeOne assets and Revolution Medicines’ four clinical RAS(ON) inhibitors: daraxonrasib, a RAS(ON) multi-selective inhibitor; zo
OpenGate Capital to Acquire Maersk Training, the Global Safety Training and Gas-Safety Services Business of Maersk10.8.2026 09:00:00 EEST | Press release
OpenGate Capital (“OpenGate”), a global private equity firm, announced today that it has signed a definitive agreement to acquire Maersk Training and its subsidiary Maersk H2S Safety Services. The company, a provider of global safety training and gas safety services, is being carved out from A.P. Møller - Mærsk A/S (MAERSK A:CPH), a listed integrated logistics company. Headquartered in Svendborg, Denmark, Maersk Training is a leading global provider of essential safety services that operates through two complementary business segments. The first segment, Maersk H2S Safety Services, is a specialist provider of outsourced hydrogen sulphide and Health, Safety and Environment safety services, which include onsite supervision, monitoring and safety equipment maintenance for customers in high-risk operating environments. The second segment, Training Business, is a global provider of safety training, competency development and simulation, delivered through instructor led, digital and virtual
Ant International’s Bettr Partners with Muslim Pro to Introduce Umrah Financing Service in Malaysia10.8.2026 06:49:00 EEST | Press release
Bettr, a leading provider of inclusive and embedded finance and fintech solutions under Ant International, today announced its partnership with Muslim Pro, a popular Islamic lifestyle app serving over 190 million downloads worldwide, to launch an Umrah financing solution in Malaysia. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260809780047/en/ Ant International's Bettr and Muslim Pro launch an Umrah financing solution in Malaysia to help families better manage their cash flow and spread pilgrimage costs responsibly. The solution is designed for eligible Muslims who have the means to undertake the pilgrimage but prefer to spread its cost over time. This flexibility enables individuals and families to manage their cash flow responsibly, maintain regular savings and preserve sufficient liquidity for emergencies and other financial obligations. The launch marks a significant milestone in Bettr’s Islamic finance initiative and
ICC Arbitral Tribunal Issues Quantum Award for AOP Health in BESREMi® Proceedings7.8.2026 20:48:00 EEST | Press release
An ICC Arbitral Tribunal has awarded AOP Orphan Pharmaceuticals GmbH (“AOP Health”) a total of about EUR 112 Mio in a quantum award issued in the ongoing arbitration proceedings with PharmaEssentia Corp. (“PharmaEssentia”) concerning BESREMi® (ropeginterferon alfa-2b). The award quantifies AOP Health’s damage claims for PharmaEssentia’s intentional breaches at ca. EUR 82 Mio. It also awards AOP Health ca. EUR 31 Mio plus interest as reimbursement for AOP Health overpayments made to PharmaEssentia as a result of excessive pricing in the years 2019-2022. The Tribunal thereby confirmed that PharmaEssentia has been overcharging AOP Health by up to 900% over these years. The Tribunal affirmed AOP Health's valid set-off of the profit-sharing payments amount owed to PharmaEssentia of approximately EUR 17 Mio against AOP Health's substantially exceeding damages claims. This means that AOP Health shall not make any payment to PharmaEssentia. Interest on AOP Health’s claims will continue to accr
Coulson Aviation Canada Acquires 10 Former RCAF Hercules, Doubling C-130H Fleet7.8.2026 20:16:00 EEST | Press release
Coulson Aviation Canada, the Canadian division of Coulson Aviation, has acquired 10 former Royal Canadian Air Force CC-130H Hercules aircraft from the Government of Canada. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260807019094/en/ Britton Coulson, left, and Wayne Coulson stand in front of one of 10 former Royal Canadian Air Force CC-130H Hercules aircraft recently acquired by Coulson Aviation from the Government of Canada. At right is a Coulson C-130H outfitted for aerial firefighting with the company’s proprietary RADS-XXL retardant delivery system, capable of carrying up to 4,000 U.S. gallons, or more than 15,000 litres, of water or fire retardant. The acquisition doubles Coulson’s global C-130H fleet to 20 aircraft, expanding its capacity to build the world’s largest C-130 airtanker fleet. The acquisition doubles Coulson’s global C-130H fleet from 10 aircraft to 20 and gives its Canadian division the scale to build
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom